| Taylor Battaglia, OD | |
|
887 Old Country Rd Ste K-l, Riverhead, NY 11901-2115 | |
| (631) 727-2858 | |
| Not Available |
| Full Name | Taylor Battaglia |
|---|---|
| Gender | Female |
| Speciality | Optometrist |
| Location | 887 Old Country Rd Ste K-l, Riverhead, New York |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1467948299 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 008834 (New York) | Primary |
| Provider Name | Sound Vision Care, Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1487809406 PECOS PAC ID: 5496801417 Enrollment ID: O20090916000485 |
News Archive
An artificial pancreas system that closely mimics the body's blood sugar control mechanism was able to maintain near-normal glucose levels without causing hypoglycemia in a small group of patients. The system, combining a blood glucose monitor and insulin pump technology with software that directs administration of insulin and the blood-sugar-raising hormone glucagon, was developed at Boston University.
Third-year residents in the Department of Family and Community Medicine at Thomas Jefferson University Hospital have organized a symposium examining racial and ethnic health disparities, with a focus on cancer care. The program will feature a keynote speech from Otis Brawley, MD, Chief Medical Officer of the American Cancer Society.
The University of Maryland's (UM) School of Dentistry has teamed up with the UM School of Medicine's R Adams Cowley Shock Trauma Center for training future dentists to respond efficiently and effectively to life threatening medical emergencies in a dental setting.
Research led by SUNY Downstate Medical Center has identified a brain receptor that appears to initiate adolescent synaptic pruning, a process believed necessary for learning, but one that appears to go awry in both autism and schizophrenia.
Omthera Pharmaceuticals, Inc., a privately-held emerging specialty pharmaceuticals company, announced today that the first patient has been dosed in its pivotal Phase III EVOLVE (EpanoVa fOr Lowering Very high triglyceridEs) trial for Epanova™, the Company's lead compound for the treatment of patients with very high triglycerides. Epanova is an Omega-3 fatty acid containing a novel formulation of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA).
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Taylor Battaglia, OD 1907 Cobblestone Ct, Middle Island, NY 11953-1472 Ph: () - | Taylor Battaglia, OD 887 Old Country Rd Ste K-l, Riverhead, NY 11901-2115 Ph: (631) 727-2858 |
News Archive
An artificial pancreas system that closely mimics the body's blood sugar control mechanism was able to maintain near-normal glucose levels without causing hypoglycemia in a small group of patients. The system, combining a blood glucose monitor and insulin pump technology with software that directs administration of insulin and the blood-sugar-raising hormone glucagon, was developed at Boston University.
Third-year residents in the Department of Family and Community Medicine at Thomas Jefferson University Hospital have organized a symposium examining racial and ethnic health disparities, with a focus on cancer care. The program will feature a keynote speech from Otis Brawley, MD, Chief Medical Officer of the American Cancer Society.
The University of Maryland's (UM) School of Dentistry has teamed up with the UM School of Medicine's R Adams Cowley Shock Trauma Center for training future dentists to respond efficiently and effectively to life threatening medical emergencies in a dental setting.
Research led by SUNY Downstate Medical Center has identified a brain receptor that appears to initiate adolescent synaptic pruning, a process believed necessary for learning, but one that appears to go awry in both autism and schizophrenia.
Omthera Pharmaceuticals, Inc., a privately-held emerging specialty pharmaceuticals company, announced today that the first patient has been dosed in its pivotal Phase III EVOLVE (EpanoVa fOr Lowering Very high triglyceridEs) trial for Epanova™, the Company's lead compound for the treatment of patients with very high triglycerides. Epanova is an Omega-3 fatty acid containing a novel formulation of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA).
› Verified 1 days ago
A & H Optometry Care P.c. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1768 Old Country Rd, Riverhead, NY 11901 Phone: 631-655-0125 | |
Taylor Elizabeth Rado, Optometrist Medicare: Medicare Enrolled Practice Location: 54 Commerce Ave, Riverhead, NY 11901 Phone: 631-727-0880 | |
Dr. Miki Lyn Zilnicki, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 25 Cranberry St, Suite A, Riverhead, NY 11901 Phone: 631-740-9384 Fax: 631-740-9385 | |
Dr. Cynthia Jarah Wiener, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 887 Old Country Rd, Riverhead, NY 11901 Phone: 631-727-2858 | |
National Vision Inc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1094 Old Country Rd, Riverhead, NY 11901 Phone: 631-655-0290 | |
Dr. Jeffrey Slaney Williams Sr., O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 887 Old Country Rd, Suite K-l, Riverhead, NY 11901 Phone: 631-727-2858 Fax: 631-727-2866 | |
David Anthony Rodriguez, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1094 Old Country Rd, Riverhead, NY 11901 Phone: 631-655-0290 |